Physician profile
Robert Li
NPI 1255619698
$2,438.86
in general payments reported to CMS, 2019-2025
17 companies · $265 in 2025
The $265 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $728 · 2020: $121 · 2021: $278 · 2022: $87.57 · 2023: $746 · 2024: $214 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,224.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,620.97 | 2019-2025 | Mako, Gamma, T2 Alpha |
| Acumed LLC | $213.67 | 2024 | Inframe Implant, Acumed |
| Depuy Synthes Sales INC. | $156.21 | 2019-2023 | Orthovisc |
| Horizon Therapeutics Plc | $106.12 | 2020-2022 | |
| Convatec INC. | $67.08 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $47.76 | 2019 | |
| Orthofix Medical, INC. | $45.43 | 2019 | |
| Pacira Therapeutics, INC. | $34.90 | 2019 | |
| Baxter Healthcare | $27.24 | 2025 | Tisseel |
| Ermi LLC | $24.12 | 2019 | |
| Ethicon US, LLC | $22.46 | 2025 | Dermabond Prineo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.89 | 2021 | |
| Anika Therapeutics, INC. | $15.81 | 2019 | |
| Molnlycke Health Care US, LLC | $15.69 | 2023 | Mepilex Border Ag, Mepilex Border Flex, Mepilex Border Sacrum |
| Pacira Pharmaceuticals Incorporated | $14.61 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $10.90 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.